There are some pharma stocks to sell in April. Holding these companies is too risky, especially as the industry faces increasing regulatory scrutiny and pricing pressures. Several major pharmaceutical firms are grappling with patent cliffs, where key drug exclusivities are expiring. This opens the door for generic competition. Moreover, with the broader market presenting attractive
0 Comments
Legendary investor Peter Lynch coined the term “tenbagger”. It refers to stocks that increase 10 times in value, generating 1,000% returns for early investors. In his investing bible, “One Up on Wall Street,” Lynch revealed his methodology for identifying these massive winners early. So what should investors look for in potential tenbagger Peter Lynch stocks?
0 Comments
The tech industry is a fertile ground for exploration in the current dynamic market scenario, promising significant returns for investors. Let’s delve into the emerging potential of three renowned technology businesses. The first company’s strategic expansion of its Shield SaaS services into the Philippines is a testament to its proactive approach, showcasing its ability to
0 Comments
Lithium carbonate, the rare earth mineral needed to make lithium-ion batteries that power everything from electric vehicles to smartphones, had seen quite some price pressure since interest rates became elevated towards the end of 2022. Looking at lithium prices today, the story is a bit different. While lithium carbonate prices have fallen more than 48%
0 Comments